Frankfurt, Germany, 13 September 2025 —15th edition of FAFA 2025, the annual Frankfurt Academy for Arrhythmias, one of the field's influential academic events, brought together of thought leaders and innovators in the field of cardiac electrophysiology. Shanghai MicroPort EP MedTech Co., Ltd. (hereinafter referred to as "MicroPort EP") made a strong impression with a comprehensive showcase featuring electrophysiology innovations, live procedures.

With one groundbreaking live-streamed procedure, PVC Ablation using Columbus Novel Mapping System, MicroPort EP featured in its first LIVE case at the FAFA congress in Germany.

The procedure, completed in less than two hours, highlighted the clinical advantages of MicroPort EP's advanced technologies.

FireMagic™ TrueForce™ Ablation Catheter was commended for its enhanced stiffness, offering improved handling, stability, and ablation efficacy. Its EI Index, integrating real-time contact force values and force vector display, provides reliable lesion assessment and procedural guidance.

The Columbus™ system was praised for delivering high-quality IECG signals that enable accurate mapping, while its faster mapping process enhances overall procedural efficiency.

The PVC procedure was successfully completed using the standard workflow and validated with our AI-powered PVC Ablation Origin technology.

By combining electrophysiology with AI, the system is designed to help physicians locate arrhythmic origins more efficiently, potentially enabling smoother and more precise procedures. This approach highlights the growing role of AI in supporting clinical decision-making and enhancing procedural confidence in cardiac care.  

Both operators also expressed enthusiasm for MicroPort EP's upcoming innovations, including the EasyStars™ High-Density Mapping Catheter, IceMagic™ Cryoablation System, and PulseMagic™ PFA System.

This successful live demonstration marks a significant step forward in showcasing MicroPort EP's commitment to advancing cardiac electrophysiology through innovation and collaboration with leading physicians worldwide.

Up to now, the Columbus™ system has been used in performing over 80,000 3D cases in more than 30 countries. The system has demonstrated stability and reliability globally.

MicroPort EP remains committed to driving forward technological innovation in electrophysiology, delivering world-class, integrated interventional solutions that empower both physicians and patients with reliable medical care.